Longitudinal Stripping Massage vs. Percussion Device for Neck Pain: Ultrasound Study.
14 июня 2026 г. обновлено: Dawid Łochyński, Poznan University of Physical Education
The Effect of Percussion Therapy on Neck Functional Disability, Pain and Upper Trapezius Muscle Properties Assessed by Elastography and Doppler Ultrasound in Patients With Neck Pain.
This study evaluates whether a single session of percussion therapy can reduce muscle tension and increase blood flow in the transverse cervical artery in individuals with neck pain.
The investigators will evaluate muscle stiffness using ultrasound elastography, and assess blood flow in the transverse cervical artery via Doppler imaging before and after treatment.
The primary objective is to determine how this therapy affects neck muscle relaxation and vascular responses, specifically within the upper trapezius region.
Обзор исследования
Статус
Рекрутинг
Условия
Вмешательство/лечение
Тип исследования
Интервенционный
Регистрация (Оцененный)
35
Фаза
- Непригодный
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Места учебы
-
-
-
Poznan, Польша, 61-871
- Рекрутинг
- Poznań University of Physical Education
-
Контакт:
- Dawid Łochyński, PhD, Assoc. Prof.
- Номер телефона: (61) 835 54 49
- Электронная почта: lochynski@awf.poznan.pl
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
Принимает здоровых добровольцев
Нет
Описание
Inclusion Criteria:
- Age: 18-60 years
- Neck pain persisting for at least 3 months
- Visual Analog Scale (VAS) score between 3 and 7
- Neck Disability Index (NDI) between 30% and 48%
Exclusion Criteria:
- Pregnancy and postpartum period
- History of cervical spine or shoulder surgery
- Diagnosed fibromyalgia, radiculopathy, or myelopathy
- Myofascial therapy within the last 3 months
- Use of analgesic medication within 48 hours before assessment
- Venous diseases
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Назначение кроссовера
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Percussion Therapy Arm
Subjects receiving percussion therapy using a massage device.
Theragun device applied to dominant side of upper trapezius muscle.
Session duration: 3 minutes.
|
Theragun device applied to dominant side of upper trapezius muscle.
Session duration: 3 minutes.
|
|
Экспериментальный: Longitudinal Stripping Massage Arm
Subjects receiving manual longitudinal stripping massage.
Longitudinal stripping massage of dominant side of upper trapezius muscle.
Session duration: 3 minutes.
|
Longitudinal stripping massage of dominant side of upper trapezius muscle.
Session duration: 3 minutes.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Neck pain intensity on Visual Analog Scale (VAS)
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Neck pain intensity evaluated using a Visual Analog Scale slide scale (score range 0-10, where 0 = no pain and 10 = worst imaginable pain).
The patient marks their pain level using the slider, and the result is recorded as a numerical score.
Unit of Measure: points
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Neck pain-related disability on Neck Disability Index (NDI)
Временное ограничение: Baseline, 2 days post-therapy (follow-up), immediately before next therapy session, and 2 days post-second therapy (final follow-up)
|
Neck pain-related disability measured with the Neck Disability Index (score range 0-50 points, where higher scores indicate greater disability).
Unit of Measure: points
|
Baseline, 2 days post-therapy (follow-up), immediately before next therapy session, and 2 days post-second therapy (final follow-up)
|
|
Shear-wave elastography of upper trapezius muscle: mean stiffness
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Ultrasound shear-wave elastography of the upper trapezius muscle at the midpoint (foramen magnum-acromion line) to evaluate the mean stiffness value.
Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral.
Probe placed at the midpoint of the trapezius.
Ultrasound gel applied for optimal contact.
The measurement is performed 3 times and the average value is used; repeated if discrepancies.
Same researcher throughout.
Unit of Measure: kilopascals (kPa)
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Myotonometry of upper trapezius muscle: oscillation frequency
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Assessment of myofascial tissue tone (oscillation frequency) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device.
Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral.
Probe placed perpendicular to the muscle surface at the midpoint of the trapezius.
Same researcher throughout.
Unit of Measure: hertz (Hz)
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Myotonometry of upper trapezius muscle: dynamic stiffness
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Assessment of biomechanical properties (dynamic stiffness) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device.
Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral.
Probe placed perpendicular to the muscle surface at the midpoint of the trapezius.
Same researcher throughout.
Unit of Measure: newtons per meter (N/m)
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Myotonometry of upper trapezius muscle: decrement
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Assessment of viscoelastic properties (logarithmic decrement of oscillation, reflecting elasticity) of the upper trapezius at the midpoint (foramen magnum-acromion line) using MyotonPRO device.
Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral.
Probe placed perpendicular to the muscle surface at the midpoint of the trapezius.
Same researcher throughout.
Unit of Measure: dimensionless
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Active cervical range of motion: flexion
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Active cervical range of motion (flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band.
The patient is seated upright with feet flat on the floor, head in neutral position.
The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded.
All measurements performed by the same researcher.
Unit of Measure: degrees
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Active cervical range of motion: extension
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Active cervical range of motion (extension) measured using EasyAngle goniometer mounted on the patient's head with an elastic band. The patient is seated upright with feet flat on the floor, head in neutral position. The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded. All measurements performed by the same researcher. Unit of Measure: degrees |
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Active cervical range of motion: right lateral flexion
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Active cervical range of motion (right lateral flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band.
The patient is seated upright with feet flat on the floor, head in neutral position.
The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded.
All measurements performed by the same researcher.
Unit of Measure: degrees
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Active cervical range of motion: left lateral flexion
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Active cervical range of motion (left lateral flexion) measured using EasyAngle goniometer mounted on the patient's head with an elastic band.
The patient is seated upright with feet flat on the floor, head in neutral position.
The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded.
All measurements performed by the same researcher.
Unit of Measure: degrees
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Active cervical range of motion: right rotation
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Active cervical range of motion (right rotation) measured using EasyAngle goniometer mounted on the patient's head with an elastic band.
The patient is seated upright with feet flat on the floor, head in neutral position.
The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded.
All measurements performed by the same researcher.
Unit of Measure: degrees
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Active cervical range of motion: left rotation
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Active cervical range of motion (left rotation) measured using EasyAngle goniometer mounted on the patient's head with an elastic band.
The patient is seated upright with feet flat on the floor, head in neutral position.
The movement is performed 3 times from neutral (goniometer recalibrated to 0° between trials) and the mean value is recorded.
All measurements performed by the same researcher.
Unit of Measure: degrees
|
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Peak systolic velocity (Vs) of the transverse cervical artery.
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Doppler ultrasound of the transverse cervical artery to evaluate Vs. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout. Unit of Measure: millimeters per second (mm/s) |
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
End-diastolic velocity (Vd) of the transverse cervical artery.
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Doppler ultrasound of the transverse cervical artery to evaluate Vd. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout. • Unit of Measure: millimeters per second (mm/s) |
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
|
Resistive index (RI) of the transverse cervical artery.
Временное ограничение: Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Doppler ultrasound of the transverse cervical artery to evaluate RI. Measurements performed supine with head stabilized, arms alongside body, cervical spine neutral. Probe positioned over the transverse cervical artery. Ultrasound gel applied for optimal contact. The measurement is performed 3 times and the mean value is used; repeated if discrepancies. Same researcher throughout. • Unit of Measure: dimensionless (lub ratio / score) |
Baseline, 20 minutes post-therapy, 2 days post-therapy (follow-up), immediately before next therapy session, 20 minutes post-second therapy, and 2 days post-second therapy (final follow-up)
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования (Оцененный)
1 июня 2026 г.
Первичное завершение (Оцененный)
1 июня 2028 г.
Завершение исследования (Оцененный)
1 июня 2029 г.
Даты регистрации исследования
Первый отправленный
1 июня 2026 г.
Впервые представлено, что соответствует критериям контроля качества
1 июня 2026 г.
Первый опубликованный (Действительный)
5 июня 2026 г.
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
17 июня 2026 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
14 июня 2026 г.
Последняя проверка
1 июня 2026 г.
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 667/21
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
НЕТ
Описание плана IPD
Individual participant data will not be shared to protect patient privacy and confidentiality in accordance with GDPR regulations and local bioethics committee guidelines.
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Нет
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Нет
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .